Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. KPRX
KPRX logo

KPRX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

KPRX News

Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders

Oct 30 2025PRnewswire

HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target

Mar 28 2025Benzinga

HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target

Nov 12 2024Benzinga

Kiora Pharmaceuticals gets approval to initiate mid-stage trial for eye disorder treatment

Oct 29 2024SeekingAlpha

Buy Rating on Kiora Pharmaceuticals: Strong Financials and Promising KIO-301 Progress

Aug 10 2024Business Insider

KPRX Stock Earnings: Kiora Pharmaceuticals Beats EPS for Q2 2024

Aug 09 2024Business Insider

HC Wainwright & Co. Maintains Buy on Kiora Pharmaceuticals, Adjusts Price Target To $10 (1-9 Reverse Stock Split)

Jul 23 2024Benzinga

Buy Rating on Kiora Pharmaceuticals Amid Strong Financials and Promising Clinical Trials

May 11 2024Business Insider

KPRX Events

No data

No data

KPRX Monitor News

No data

No data

KPRX Earnings Analysis

No Data

No Data

People Also Watch